Loading...

T. Hasegawa Co., Ltd.

HASGFPNK
Basic Materials
Chemicals - Specialty
$19.82
$0.00(0.00%)

T. Hasegawa Co., Ltd. (HASGF) Financial Performance & Income Statement Overview

Analyze T. Hasegawa Co., Ltd. (HASGF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.

Revenue Growth
10.44%
10.44%
Operating Income Growth
24.83%
24.83%
Net Income Growth
7.94%
7.94%
Operating Cash Flow Growth
74.08%
74.08%
Operating Margin
15.61%
15.61%
Gross Margin
41.72%
41.72%
Net Profit Margin
11.81%
11.81%
ROE
3.54%
3.54%
ROIC
4.22%
4.22%

T. Hasegawa Co., Ltd. (HASGF) Income Statement & Financial Overview

Explore comprehensive income reports for T. Hasegawa Co., Ltd. HASGF, broken down by year and quarter.

MetricQ1 2025Q4 2024Q3 2024Q2 2024
Revenue$17.64B$18.94B$19.25B$17.04B
Cost of Revenue$10.23B$11.37B$11.02B$10.14B
Gross Profit$7.42B$7.57B$8.24B$6.90B
Gross Profit Ratio$0.42$0.40$0.43$0.41
R&D Expenses$0.00$5.55B$0.00$1.29B
SG&A Expenses$5.51B$3.04B$5.04B$3.14B
Operating Expenses$5.51B$5.69B$5.04B$4.44B
Total Costs & Expenses$15.74B$17.06B$16.05B$14.57B
Interest Income$0.00$0.00$71.00M$54.00M
Interest Expense$0.00$0.00$6.00M$6.00M
Depreciation & Amortization$1.25B$1.25B$1.15B$1.22B
EBITDA$3.16B$3.09B$4.35B$3.90B
EBITDA Ratio$0.18$0.16$0.23$0.23
Operating Income$1.90B$1.88B$3.20B$2.47B
Operating Income Ratio$0.11$0.10$0.17$0.14
Other Income/Expenses (Net)$381.00M$318.00M$244.00M$213.00M
Income Before Tax$2.28B$2.20B$3.44B$2.68B
Income Before Tax Ratio$0.13$0.12$0.18$0.16
Income Tax Expense$820.00M$612.00M$1.02B$813.00M
Net Income$1.46B$1.58B$2.42B$1.87B
Net Income Ratio$0.08$0.08$0.13$0.11
EPS$35.49$38.32$58.79$45.38
Diluted EPS$35.49$38.30$58.54$45.18
Weighted Avg Shares Outstanding$41.17M$41.33M$41.15M$41.15M
Weighted Avg Shares Outstanding (Diluted)$41.17M$41.35M$41.32M$41.32M

Financial performance has remained strong, with revenue growing from $17.04B in Q2 2024 to $17.64B in Q1 2025. Gross profit continued to perform well, with margins at 42% in the latest quarter. Operating income reached $1.90B in Q1 2025, holding a steady 11% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $3.16B. Net income dropped to $1.46B, keeping EPS at $35.49. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;